Observational studies of drugs and mortality

被引：41

作者：

Ray, WA ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Dept Prevent Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA

[2] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 22期

关键词：

D O I：

10.1056/NEJMp058267

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2319 / 2321

页数：3

相关论文

共 5 条

[1] COX-2 inhibitors - Lessons in drug safety [J].

Psaty, BM ;

Furberg, CD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1133-1135

[2] Evaluating medication effects outside of clinical trials: New-user designs [J].

Ray, WA .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (09) :915-920

[3] Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores:: Nonsteroidal antiinflammatory drugs and short-term mortality in the elderly [J].

Stürmer, T ;

Schneeweiss, S ;

Brookhart, MA ;

Rothman, KJ ;

Avorn, J ;

Glynn, RJ .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (09) :891-898

[4] Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease - Immortal time bias in observational studies [J].

Suissa, S .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (01) :49-53

[5] Choice of clinical outcomes in randomized trials of heart failure therapies: Disease-specific or overall outcomes? [J].

Yusuf, S ;

Negassa, A .

AMERICAN HEART JOURNAL, 2002, 143 (01) :22-28